Delivery Order SPE2DB22D2214-SPE2DB25FS6NS
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 162 mg/0.9 mL syringes. The contract reflects a firm fixed price arrangement with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, consistent with the vendor's track...
- The Defense Logistics Agency awarded a delivery order valued at $1,430.07 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,328.29 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Actemra 162 mg/0.9 ml syringes. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $8,050.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, which is a non-set-aside award, was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,729.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 200 mg/10 mL vials. The contract, which is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 162 mg/0.9 ml syringes. This is a firm fixed price delivery order with a completion date of September 2, 2025, with no set-aside designation applied. The contract represents a competitive award under DLA's broader pharmaceutical supply framework, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes, with a contract ceiling value of $12,196.90. This firm fixed-price delivery order, issued on August 1, 2025, carries an ultimate completion date of August 4, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $16,453.58. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and no set-aside designation was used in the award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Actemra 162 mg/0.9 ml syringes valued at $7,762.59 with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.98 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Actemra 162 mg/0.9 mL syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pediatric immunosuppressant pharmaceutical delivery supporting federal medical procurement needs. This...